152 related articles for article (PubMed ID: 31089277)
1. Parvovirus B19 infection in adult patients after allogeneic stem cell transplantation: our experience of five cases and literature review.
Katoh D; Ochi Y; Hiramoto N; Morita M; Yabushita T; Shimomura Y; Yamashita D; Ono Y; Yoshioka S; Yonetani N; Matsushita A; Imai Y; Hashimoto H; Ishikawa T
Bone Marrow Transplant; 2020 Mar; 55(3):653-656. PubMed ID: 31089277
[No Abstract] [Full Text] [Related]
2. Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation.
Wasak-Szulkowska E; Grabarczyk P; Rzepecki P
Transpl Infect Dis; 2008 Jun; 10(3):201-5. PubMed ID: 17631000
[TBL] [Abstract][Full Text] [Related]
3. Persistent parvovirus B19 infection resulting in red cell aplasia after allogeneic hematopoietic stem cell transplantation.
Koda Y; Mori T; Kato J; Kohashi S; Kikuchi T; Mitsuhashi T; Murata M; Uemura T; Handa M; Okamoto S
Transpl Infect Dis; 2013 Dec; 15(6):E239-42. PubMed ID: 24134728
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 in stem cell transplantation.
Kinsella PM; Yong MK; Slavin MA; Hall VG
Transpl Infect Dis; 2023 Oct; 25(5):e14138. PubMed ID: 37610327
[No Abstract] [Full Text] [Related]
5. [Parvovirus B19 infection in HIV-infected patients].
Petrenko AA; Dudina GA; Kremneva NV; Pivnik AV
Ter Arkh; 2020 Sep; 92(7):100-103. PubMed ID: 33346452
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immune features of human parvovirus B19 infection in allogeneic stem cell transplantation recipients: A retrospective monocentric study.
Sammut R; Feghoul L; Xhaard A; Dhedin N; Robin M; Michonneau D; Loschi M; Legoff J; de Peffault de Latour R; de Sicre de Fontbrune F
Transpl Infect Dis; 2023 Oct; 25(5):e14118. PubMed ID: 37594199
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation - Single-center experience and review.
Holterhus M; Hennies M; Hillmann H; Thorer H; Rossig C; Burkhardt B; Groll AH
Transpl Infect Dis; 2023 Apr; 25(2):e14028. PubMed ID: 36748962
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 infections.
Sabella C; Goldfarb J
Am Fam Physician; 1999 Oct; 60(5):1455-60. PubMed ID: 10524489
[TBL] [Abstract][Full Text] [Related]
9. Erythema infectiosum and other parvovirus B19 infections.
Kirchner JT
Am Fam Physician; 1994 Aug; 50(2):335-41. PubMed ID: 8042568
[TBL] [Abstract][Full Text] [Related]
10. [Various clinical symptoms in human parvovirus B19 infection].
Kumano K
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):448-53. PubMed ID: 19122375
[TBL] [Abstract][Full Text] [Related]
11. Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation.
Hayes-Lattin B; Seipel TJ; Gatter K; Heinrich MC; Maziarz RT
Am J Hematol; 2004 Mar; 75(3):142-5. PubMed ID: 14978694
[TBL] [Abstract][Full Text] [Related]
12. Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion-dependent pure red cell aplasia in multiple myeloma after allogeneic haematopoietic stem cell transplantation and severe graft versus host disease.
Karrasch M; Schmidt V; Hammer A; Hochhaus A; Rosée P; Petersen I; Sauerbrei A; Baier M; Sayer HG; Hermann B
Hematology; 2017 Mar; 22(2):93-98. PubMed ID: 27311084
[TBL] [Abstract][Full Text] [Related]
13. Pure red cell aplasia associated with parvovirus B19 infection in renal transplantation: the first case report in Mexico.
Vales-Albertos LJ; García-Cárdenas M; Chávez-Becerra S; Gómez-Navarro B; Monteón-Ramos F; Cueto-Manzano AM
Transplantation; 2005 Mar; 79(6):739. PubMed ID: 15785387
[No Abstract] [Full Text] [Related]
14. Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia.
Gahr M; Pekrun A; Eiffert H
Eur J Pediatr; 1991 May; 150(7):470-2. PubMed ID: 1915497
[TBL] [Abstract][Full Text] [Related]
15. [The hematological diversity of human parvovirus B19 infection after allo-hematopoietic stem cell transplantation in pediatric patients].
Zhang LY; Liu F; Chen X; Zhang XY; Ren YY; Zhang RR; Yang WY; Guo Y
Zhonghua Xue Ye Xue Za Zhi; 2021 Aug; 42(8):654-659. PubMed ID: 34547871
[No Abstract] [Full Text] [Related]
16. Parvovirus B19 infections.
Vafaie J; Schwartz RA
Int J Dermatol; 2004 Oct; 43(10):747-9. PubMed ID: 15485533
[TBL] [Abstract][Full Text] [Related]
17. Hematologic Manifestations of Parvovirus B19 Infection.
Algwaiz G; Alharbi A; Alsehaim K; Alahmari A; El Fakih R; Aljurf M
Hematol Oncol Stem Cell Ther; 2023 May; 16(4):316-322. PubMed ID: 37363985
[TBL] [Abstract][Full Text] [Related]
18. Pure red cell aplasia due to parvovirus B19 infection in a renal transplant patient: a case report.
So BJ; Chae KM; Lee KK; Lee YJ; Jeong BH
Transplant Proc; 2000 Nov; 32(7):1954-6. PubMed ID: 11120017
[No Abstract] [Full Text] [Related]
19. Pure red-cell aplasia due to parvovirus B19 infection in a patient with AIDS-related complex.
Taillan B; Heudier P; Ferrari E; Garnier G; Fuzibet JG; Dujardin P
Ann Med; 1992 Apr; 24(2):137. PubMed ID: 1610541
[No Abstract] [Full Text] [Related]
20. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
Tavil B; Sanal O; Turul T; Yel L; Gurgey A; Gumruk F
Pediatr Hematol Oncol; 2009 Mar; 26(2):63-8. PubMed ID: 19322736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
